Clinical trial
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
NCT00812682 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- August 31, 2007
- Enrollment
- 217 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
perception of physicians & patients of amd